NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 1,604 Shares

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 1,604 shares of NeueHealth stock in a transaction on Monday, March 10th. The stock was sold at an average price of $7.06, for a total value of $11,324.24. Following the sale, the chief executive officer now owns 184,717 shares in the company, valued at $1,304,102.02. This trade represents a 0.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

George Lawrence Mikan III also recently made the following trade(s):

• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total value of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Stock Performance

NYSE:NEUE opened at $6.92 on Wednesday. NeueHealth, Inc. has a 52-week low of $3.79 and a 52-week high of $8.32. The firm has a market cap of $57.33 million, a price-to-earnings ratio of -0.14 and a beta of 0.56. The business’s fifty day moving average is $7.33 and its 200 day moving average is $5.99.

Institutional Trading of NeueHealth

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC bought a new stake in shares of NeueHealth during the 4th quarter valued at $76,000. Northern Trust Corp raised its stake in shares of NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares during the period. Finally, Partners Group Holding AG bought a new stake in shares of NeueHealth during the 3rd quarter valued at $463,000. 63.88% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Royal Bank of Canada lowered their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.